undefined

Julian Hoffman

Expert discussing the biotech sector, potential M&A deals, and the performance of weight-loss drug companies like Novo Nordisk and Eli Lilly.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app